World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 24 April 2023
Main ID:  ISRCTN61225589
Date of registration: 06/01/2017
Prospective Registration: No
Primary sponsor: University of Jyväskylä
Public title: The usability and effectiveness of connecting technology on physical and psychosocial functioning of cardiovascular disease rehabilitees in usual rehabilitation
Scientific title: The usability and effectiveness of connecting technology on physical activity, physical and psychosocial functioning, participation and quality of life of cardiovascular disease rehabilitees - a cluster randomized trial with six month follow up in usual rehabilitation
Date of first enrolment: 21/09/2015
Target sample size: 60
Recruitment status: Completed
URL:  https://www.isrctn.com/ISRCTN61225589
Study type:  Interventional
Study design:  Parallel cluster randomized trial (Treatment)  
Phase:  Not Applicable
Countries of recruitment
Finland
Contacts
Name: Tuulikki    Sjögren
Address:  Keskussairaalantie 24 40014 Jyväskylä Finland
Telephone: +358 (0)40 169 6841
Email: tuulikki.sjogren@jyu.fi
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Coronary artery disease rehabilitee with basic skills for using internet
2. Adults and elderly, no restrictions in age

Exclusion criteria: Musculoskeletal diseases, cognitive diseases or problems with memory that clearly limit functional capacity

Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Coronary artery disease rehabilitation (chronic phase)
Circulatory System
Intervention(s)

The participants consist of 60 volunteer cardiovascular disease rehabilitees from six rehabilitation courses in a 12-month coronary artery disease rehabilitation intervention. Three of the courses are randomized to a usual rehabilitation group and the other three courses use connecting technology (Fitbit Zip® accelerometer and Movendos m-coach internet application) during usual rehabilitation.

12-month usual multidisciplinary rehabilitation consists of three five-day inpatient face-to-face rehabilitation periods in the rehabilitation center (at baseline, 6 months and 12 months) and an outpatient period between inpatient rehabilitation sessions (2 x 6 months). Quantitative data is collected with physical and psychosocial questionnaires and physical measurements. The effectiveness of the intervention on physical and psychosocial functioning are analyzed using linear mixed models. Cluster-specific methods are justified by the composition of inpatient courses, when groups rather than individuals are randomized. Qualitative data is collected with focus group interviews (baseline, 6 month and 12 months). The qualitative data is analyzed by inductive content analysis.
Primary Outcome(s)

1. Objective physical activity (total physical activity: frequency, duration, intensity and patterns of movement [and different combinations of outcomes]), measured using Fitbit Zip® accelerometer. This study uses five times one-week recall during the intervention (baseline, 3, 6, 9 and 12 months) and once during the follow up period (6 months).
2. Subjective physical activity (vigorous and moderate physical activity and walking [and different combinations of outcomes]), measured using the International Physical Activity Questionnaire (IPAQ) three times during the intervention period (baseline, 6 months and at 12 months) and once during the follow up period (6 months).
Secondary Outcome(s)

1. Physical functioning:
1.1. Cardiorespiratory fitness, evaluated using submaximal level of functional capacity by using the 6-minute walking test. Outcome measures are: maximal oxygen uptake, heart rate, walking pace, Borg scale 0-10 (ATS Statements: Guidelines for the Six-Minute Walk Test 2002). Schedule of measurements is three times during intervention period (baseline, 6 months and at 12 months) and once during the follow-up period (6 months).
1.2. Body composition. measured by weight (kg), height (cm), body mass index (BMI) and waist circumference (cm). Schedule of measurements is three times during intervention period (baseline, 6 months and at 12 months) and once during the follow-up period (6 months).
2. Quality of life, measured using The World Health Organization Quality of Life-assessment (WHOQOL-BREF). WHOQOL-BREF domains are physical health, psychological, social relationships, environment (WHOQOL Group 1996, WHOQOL Group 1998, Skevington ym. 2004). Schedule of measurements is three times during the intervention period (baseline, 6 months and at 12 months) and once during the follow-up period (6 months).
3. Adherence to treatment, measured by the times of log-in to the Movendos m-coach internet application and the amount of exercise according to the data that Movendos m-coach software has collected. The data is collected at the end of the 12-month intervention.
4. Technology acceptance, evaluated using a questionnaire (modified by Venkatesh & Bala 2008) with sections “perceived ease of use” and “perceived usefulness”. The data is collected at the end of the 12-month intervention.
5. Cost-effectiveness of connecting technology, evaluated based on the differential between the common benefits and costs. Outcomes are related to direct time-related costs of rehabilitee, rehabilitation employees and management of the rehabilitation center. The main health-related outcomes are related to physical activity and quality of life. Cost-effectiveness is evaluated during the intervention period (12 months) and during the follow-up period (6 months).
6. Expectations and attitudes towards the use of connecting technology in rehabilitation, evaluated by the data from group interviews. Interviews are performed three times during the intervention period (baseline, 6 months and at 12 months) and once during the follow-up period.
Secondary ID(s)
D number 44/26/2015
Source(s) of Monetary Support
Kela
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Ethics committee of the Central Finland Health Care District, 06/10/2015, ref: 44/26/2015
Results
Results available:
Date Posted:
Date Completed: 30/11/2017
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history